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Biotechnology innovations offer solutions to problems related to food security, poverty and environmental degradation associated with high population growth rate and intensive agriculture. However, biosafety and biodiversity concerns as well as technical and institutional capability limitations, constrain its widespread application.  Countries intending to use biotechnology products are required to implement the National Biosafety Framework (NBF) in compliance with the Cartagena Protocol on Biosafety (CPB) and develop human resource and institutional capability to undertake biotechnology research and development (R&D) and implement biosafety regulations.  
Different countries are at varying stages of biotechnology R&D, direct use or propagation and NBF implementation. Knowledge and information sharing as well as institutional support are critical for developing countries to be able to access the potential benefits of modern biotechnology.  
Objectives: This paper presents the initial results of an on-going study being conducted by a team of researchers from the Philippines, Cambodia and Lao PDR, whose ultimate goal is to help developing countries maximize the benefits of biotechnology applications for food security, poverty alleviation, and environmental conservation.  The study which covers three Southeast Asian countries (i.e., Cambodia, Lao PDR and Philippines) has a strong capacity building, knowledge sharing and networking component.  It is led by the University of the Philippines Los Baños (UPLB), one of the leading biotech R&D institutions in the Philippines in terms of human and physical resources capability and works with junior researchers in Cambodia and Lao PDR and other local Philippine universities. 
The Philippine study, an ex-post assessment, focused on the implementation of the regulatory policies related to risk assessment of genetically engineered (GE) maize as stipulated in the CBP.  The Cambodia and Lao PDR components involved ex-ante analysis of institutional issues related to the NBF adoption. Specifically, this paper will discuss the biosafety regulation system in the Philippines, which are already in place and the factors that affect the formulation and adoption of the NBFs in Cambodia and Lao PDR.
Methodology: Data and information for this study were generated through key informant interviews (KIIs) with policy makers and implementers and focus group discussions (FGDs) with farmer groups, seed suppliers and processors. The kind of data that were collected in these countries, however, differs because of the difference in research framework.  
The Philippine study focused on how the biosafety policies are implemented, the roles and performance of local government units (LGUs) and other national agencies (e.g. the National Committee on Biosafety of the Philippines or NCBP, Department of Agriculture’s Bureau of Plant Industry), the private sector and farmers’ groups and capacity building needs of regulatory policy implementers. The Cambodia and Lao-PDR studies generated information that may prove useful in finalizing the regulatory policies in these countries.  Institutional factors were analyzed to determine the constraints to institutionalization of their NBFs.  
Information provided by the respondents was validated with other stakeholders through a triangulation process to ensure consistency and reliability. Data were also obtained from secondary sources such as report of government agencies concerned to supplement the primary data.  
Results and Conclusions. The Philippines is relatively more advanced compared to its Southeast Asian neighbours with respect to biosafety regulation and biotechnology application. The policy environment in the country is conducive to the promotion and use of modern biotechnology products and there is greater awareness among scientists about the need for biosafety regulations. 
The scientists advocated the creation of organizational structures and formulation of biosafety regulations for the safe handling of biotechnology materials during laboratory experiments and field trials to prevent the escape into the environment of pernicious materials that maybe harmful to human health and the environment. Through their efforts, Executive Order 430 was issued in 1990 creating the NCBP and prompting the passage of the Philippine Biosafety Guidelines.  Several other laws guiding biotechnology R&D were passed in the ensuing years. 
The enabling environment for Biotechnology application was further boosted by the government’s policy pronouncement in 2001 on the “…safe and responsible use of modern biotechnology…” and the issuance of Executive Order 514 (2006), which established the CPB-compliant NBF and strengthened the NCBP.  The Philippines became a “Biotechnology Mega Country” in 2005, barely three years after the first commercial release of Bt maize (MON 810) in 2002.  As of May 2009, four GE maize varieties have been approved for commercial release: insect resistant Bt maize (MON810 and Bt11) in 2002, HT (NK603) in 2006 and ST (MON810xNK603) in 2006.  
Despite the relatively more advanced state of modern biotechnology applications and biosafety regulation in the Philippines, some policy concerns were still noted.  Among these are: a) the lack of farmers’ awareness about the specific crop variety that they are using (i.e., whether conventionally bred hybrid  or genetically modified); b) limited appreciation  by the local government units which are in-charge of implementing biosafety regulations such as insect resistance management and reporting the extent of GE maize plantation to the national government and information  dissemination about the various GE maize varieties available in the market; and c) slow institutionalization of the risk assessment protocol, particularly the inclusion of socio-economic  considerations in the risk assessment process. 
Lao-PDR’s national policy is to improve the level of maize production through the adoption of high-yielding maize varieties.  Biotechnology application is also seen as possible means of increasing maize production. Although the biosafety and biotechnology policies are still not yet developed, the government does not expressly prohibit farmers from growing GE crops. Lao PDR has formulated its NBF to guide scientists and government in the proper application of biotechnology to avoid health and environmental risks.  However, the framework has not yet been approved, and the implementation and regulatory policies are not yet in place. 
One of the major constraints to the official adoption of the NBF is the conflicting position of key policy makers about modern biotechnology.  The Science Technology and Environment Agency (STEA) is the local focal point of CPB implementation and is pushing for NBF adoption. However, key officials of the Ministry of Agriculture and Forestry are against modern biotechnology application, particularly genetic modification of food crops. Thus, STEA does not get the support of other government agencies in the institutionalization of biosafety regulations. 
In Cambodia, agriculture contributes about 33.5 percent to the total gross domestic product (2009) in which crops represent the largest share (59%).  The sector has shown some changes in recent years, particularly in increasing production and yield.  However, crop productivity in Cambodia remains the lowest in the region and have not benefitted from modern agricultural production practices. There has been a growing recognition on the great promise offered by biotechnology in improving agricultural productivity and profitability.  Despite this efforts, application of biotechnology in agricultural R&D in Cambodia lags far behind other countries in the region. Current research almost focuses entirely on natural breeding for plants, crops and animals, with emphasis on selection for resistance to diseases, pests, and drought to boost agriculture. Only recently has the country embarked on tissue culture technique in its plant breeding program for bananas.
Recent years have seen considerable efforts to put in place regulatory and policy frameworks relevant for biotechnology application in the country.  This began with the promulgation of the “Law on Biosafety” on 15 February 2008.  Further efforts include the formulation of a Sub-decree on living modified organisms (LMO) and genetically modified organisms (GMO). The Sub-Decree on LMOs Management and Control being drafted aims to implement the Law on Biosafety and regulate risks that might occur from handling, transfer, transport and use of LMOs in Cambodia.  In spite of these positive developments, Cambodia is currently apparently not yet ready, institutionally and technically, to embark on biotechnology to reap socio-economic benefits from GE crops.
Like in Lao PDR, key policymakers in Cambodia such as the officials of the General Directorate of Agriculture and the Cambodian Agricultural Research and Development Institute are not yet open to the use of modern biotechnology particularly genetic engineering involving food crops. It is interesting to note, however, that Cambodia is leasing out lands to  China for use in Bt cotton production. So far, Cambodian authorities have not yet invoked their NBF to regulate the entry of Bt cotton materials from China nor have they monitored the possible spread of Bt cotton materials in other parts of the country. 
Recommendations: These findings imply the need for greater coordination among the institutions involved in biosafety regulations, more in-depth information dissemination and knowledge sharing with key decision makers concerned with agricultural biotechnology R&D and regulatory policy formulation as well as greater institutional support to develop the R&D and regulatory capabilities of Lao PDR and Cambodia. 
For the Philippines, there is need for: a) capacity building of local policy implementers, particularly the agricultural extension workers for them to have greater appreciation of their role biosafety regulation implementation such as insect resistance management and monitoring GE maize plantation for more accurate reporting of national statistics; and b) greater coordination between the private sector, particularly, the seed suppliers and the government extension workers to inform farmers about the particular crop variety they are using and the related biosafety concerns.    



